Soumit Roy
Stock Analyst at JonesTrading
(1.60)
# 2,272
Out of 4,414 analysts
20
Total ratings
25%
Success rate
-6.82%
Average return
Main Sectors:
Top Industries:
14 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DCPH Deciphera Pharmaceuticals | Downgrades: Hold | $26 | $25.38 | +0.87% | 3 | Apr 29, 2024 | |
| CGEM Cullinan Oncology | Maintains: Buy | $22 → $26 | $27.58 | -5.73% | 2 | Apr 17, 2024 | |
| JANX Janux Therapeutics | Initiates: Buy | $70 | $62.43 | +12.13% | 1 | Apr 16, 2024 | |
| MNPR Monopar Therapeutics | Upgrades: Buy | $2 | $0.66 | +203.03% | 2 | Apr 11, 2024 | |
| INAB IN8bio | Initiates: Buy | $5 | $1.02 | +390.20% | 1 | Mar 13, 2024 | |
| TCON TRACON Pharmaceuticals | Downgrades: Hold | n/a | $1.81 | - | 2 | Aug 21, 2023 | |
| ACRV Acrivon Therapeutics | Initiates: Buy | $26 | $8.46 | +207.33% | 1 | Aug 18, 2023 | |
| ONCY Oncolytics Biotech | Initiates: Buy | $9 | $1.17 | +669.23% | 1 | May 24, 2023 | |
| COEP Coeptis Therapeutics | Initiates: Buy | $4 | $0.37 | +982.25% | 1 | Apr 19, 2023 | |
| IKT Inhibikase Therapeutics | Downgrades: Hold | n/a | $1.34 | - | 2 | Nov 16, 2022 | |
| HCWB HCW Biologics | Initiates: Buy | $8 | $1.32 | +506.06% | 1 | Nov 8, 2022 | |
| ACET Adicet Bio | Initiates: Buy | n/a | $1.41 | - | 1 | Apr 29, 2021 | |
| SAVA Cassava Sciences | Initiates: Buy | n/a | $22.06 | - | 1 | Mar 17, 2021 | |
| DTIL Precision BioSciences | Initiates: Buy | $810 | $10.84 | +7,372.32% | 1 | Feb 24, 2021 |
Deciphera Pharmaceuticals
Apr 29, 2024
Downgrades: Hold
Price Target: $26
Current: $25.38
Upside: +0.87%
Cullinan Oncology
Apr 17, 2024
Maintains: Buy
Price Target: $22 → $26
Current: $27.58
Upside: -5.73%
Janux Therapeutics
Apr 16, 2024
Initiates: Buy
Price Target: $70
Current: $62.43
Upside: +12.13%
Monopar Therapeutics
Apr 11, 2024
Upgrades: Buy
Price Target: $2
Current: $0.66
Upside: +203.03%
IN8bio
Mar 13, 2024
Initiates: Buy
Price Target: $5
Current: $1.02
Upside: +390.20%
TRACON Pharmaceuticals
Aug 21, 2023
Downgrades: Hold
Price Target: n/a
Current: $1.81
Upside: -
Acrivon Therapeutics
Aug 18, 2023
Initiates: Buy
Price Target: $26
Current: $8.46
Upside: +207.33%
Oncolytics Biotech
May 24, 2023
Initiates: Buy
Price Target: $9
Current: $1.17
Upside: +669.23%
Coeptis Therapeutics
Apr 19, 2023
Initiates: Buy
Price Target: $4
Current: $0.37
Upside: +982.25%
Inhibikase Therapeutics
Nov 16, 2022
Downgrades: Hold
Price Target: n/a
Current: $1.34
Upside: -
HCW Biologics
Nov 8, 2022
Initiates: Buy
Price Target: $8
Current: $1.32
Upside: +506.06%
Adicet Bio
Apr 29, 2021
Initiates: Buy
Price Target: n/a
Current: $1.41
Upside: -
Cassava Sciences
Mar 17, 2021
Initiates: Buy
Price Target: n/a
Current: $22.06
Upside: -
Precision BioSciences
Feb 24, 2021
Initiates: Buy
Price Target: $810
Current: $10.84
Upside: +7,372.32%